Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential

Published:2021-07-09 Issue:8 Volume:30 Page:877-891
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Flintoff Jonathan¹,Kesby James P¹²^ORCID,Siskind Dan³⁴^ORCID,Burne Thomas HJ¹³^ORCID

Affiliation:

1. Queensland Brain Institute, the University of Queensland, St Lucia, QLD, Australia

2. QIMR Berghofer Medical Research Institute, Herston, QLD, Australia

3. Queensland Centre for Mental Health Research, Wacol, QLD, Australia

4. Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1951702

Reference144 articles.

1. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis

2. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

3. Impaired Glucose Homeostasis in First-Episode Schizophrenia

4. Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders

5. Brain insulin action: Implications for the treatment of schizophrenia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study;eClinicalMedicine;2024-08

2. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model;Biomedicine & Pharmacotherapy;2024-07

3. Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry;The Journal of Neuropsychiatry and Clinical Neurosciences;2024-04

4. Insight into mitochondrial dysfunction mediated by clozapine-induced inhibition of PGRMC1 in PC12 cells;Toxicology;2023-06

5. GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice;Behavioural Brain Research;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3